A Phase 2a trial of OPK88002 to treat pruritus (itching) in Stage 5 CKD patients undergoing dialysis

Trial Profile

A Phase 2a trial of OPK88002 to treat pruritus (itching) in Stage 5 CKD patients undergoing dialysis

Planning
Phase of Trial: Phase II

Latest Information Update: 08 Aug 2017

At a glance

  • Drugs OPK88002 (Primary)
  • Indications Pruritus
  • Focus Therapeutic Use
  • Sponsors OPKO Health
  • Most Recent Events

    • 08 Aug 2017 According to an Opko health media release, this study expected to begin in late 2017.
    • 08 Aug 2017 According to an Opko health media release, Investigational New Drug application has been approved.
    • 06 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top